Quarter Financials
NeuBase Therapeutics, Inc. (NBSE)
$0.1767
+0.00 (+0.97%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
|---|
| Net Income | -4 | 8 | -8 | -10 | -7,729 | -25 | -9 | -6 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -107 | -103 | -95 | -87 | -77 | -69 | -62 | -53 |
|---|
|
Year
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
|---|
| Capital Expenditure | - | - | -0 | -0 | - | - | -1 | -0 |
|---|
| Net PPE | 5 | 6 | 8 | 8 | 6 | 6 | 8 | 2 |
|---|
|
Year
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
|---|
| New Purchases | -15 | -15 | -15 | -15 | - | -15 | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|